North Star Investment Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Hold
300
– – ﹤0.01% 924
2026
Q1
$29.8K Buy
+300
New +$39.1K ﹤0.01% 841
2024
Q2
– Sell
-100
Closed -$7.39K – 1235
2024
Q1
$7.39K Buy
+100
New +$8.24K ﹤0.01% 910
2023
Q4
– Sell
-101
Closed -$5.53K – 1278
2023
Q3
$5.53K Hold
101
– – ﹤0.01% 935
2023
Q2
$8.48K Sell
101
-149
-60% -$11.4K ﹤0.01% 881
2023
Q1
$18.9K Hold
250
– – ﹤0.01% 769
2022
Q4
$15.4K Buy
+250
New +$13.3K ﹤0.01% 781

Other funds holding TMDX

North Star Investment Management's TMDX Position: Q2 2026 in Review

North Star Investment Management held its Transmedics (TMDX) position steady in Q2 2026 at 300 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

North Star Investment Management first reported a position in TMDX in Q4 2022 and has held it in 7 quarters since. The position peaked at $29.8K in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • North Star Investment Management held 300 shares of Transmedics worth $19.9K as of Q2 2026.
  • North Star Investment Management left its Transmedics share count unchanged in Q2 2026.
  • Transmedics made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #924 holding.
  • North Star Investment Management first reported a position in Transmedics in Q4 2022 and has held it in 7 quarters since.
  • North Star Investment Management's Transmedics position peaked at $29.8K in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.